Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 187

1.

FGFR1 Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor-Positive (HR+) Breast Cancer.

Drago JZ, Formisano L, Juric D, Niemierko A, Servetto A, Wander SA, Spring LM, Vidula N, Younger J, Peppercorn J, Yuen M, Malvarosa G, Sgroi D, Isakoff SJ, Moy B, Ellisen LW, Iafrate AJ, Arteaga CL, Bardia A.

Clin Cancer Res. 2019 Aug 1. doi: 10.1158/1078-0432.CCR-19-0138. [Epub ahead of print]

PMID:
31371343
2.

Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer.

Medford AJ, Dubash TD, Juric D, Spring L, Niemierko A, Vidula N, Peppercorn J, Isakoff S, Reeves BA, LiCausi JA, Wesley B, Malvarosa G, Yuen M, Wittner BS, Lawrence MS, Iafrate AJ, Ellisen L, Moy B, Toner M, Maheswaran S, Haber DA, Bardia A.

NPJ Precis Oncol. 2019 Jul 16;3:18. doi: 10.1038/s41698-019-0090-5. eCollection 2019.

3.

Brachytherapy as an Adjuvant for Recurrent Atypical and Malignant Meningiomas.

Koch MJ, Agarwalla PK, Royce TJ, Shih HA, Oh K, Niemierko A, Mauceri TC, Curry WT, Barker FG, Loeffler JS.

Neurosurgery. 2019 Apr 24. pii: nyz115. doi: 10.1093/neuros/nyz115. [Epub ahead of print]

PMID:
31329941
4.

Patterns of Care and Outcomes of Definitive External Beam Radiotherapy and Radioembolization for Localized Hepatocellular Carcinoma: A Propensity Score-adjusted Analysis.

Bitterman DS, Sanford NN, Niemierko A, Mahal BA, Qadan M, Ganguli S, Blaszkowsky LS, Zhu AX, Hong TS, Devlin PM, Goyal L, Wo JY.

Am J Clin Oncol. 2019 Jul;42(7):564-572. doi: 10.1097/COC.0000000000000560.

PMID:
31166209
5.

Patterns of Failure Among Patients With Low-grade Glioma Treated With Proton Radiation Therapy.

Kamran SC, Dworkin M, Niemierko A, Bussiere M, Oh KS, Loeffler JS, Shih HA.

Pract Radiat Oncol. 2019 Jul - Aug;9(4):e356-e361. doi: 10.1016/j.prro.2019.02.002. Epub 2019 Feb 18.

PMID:
30790717
6.

Radiation tolerance of the optic pathway in patients treated with proton and photon radiotherapy.

Li PC, Liebsch NJ, Niemierko A, Giantsoudi D, Lessell S, Fullerton BC, Adams J, Shih HA.

Radiother Oncol. 2019 Feb;131:112-119. doi: 10.1016/j.radonc.2018.12.007. Epub 2018 Dec 31.

PMID:
30773177
7.

Hypopituitarism After Cranial Irradiation for Meningiomas: A Single-Institution Experience.

Lamba N, Bussiere MR, Niemierko A, Abedi P, Fullerton BC, Loeffler JS, Oh KS, Nachtigall LB, Shih HA.

Pract Radiat Oncol. 2019 May;9(3):e266-e273. doi: 10.1016/j.prro.2019.01.009. Epub 2019 Feb 4.

PMID:
30731274
8.

Report of the AAPM TG-256 on the relative biological effectiveness of proton beams in radiation therapy.

Paganetti H, Blakely E, Carabe-Fernandez A, Carlson DJ, Das IJ, Dong L, Grosshans D, Held KD, Mohan R, Moiseenko V, Niemierko A, Stewart RD, Willers H.

Med Phys. 2019 Mar;46(3):e53-e78. doi: 10.1002/mp.13390. Epub 2019 Feb 14.

PMID:
30661238
9.

Risk stratification by somatic mutation burden in Ewing sarcoma.

Liu KX, Lamba N, Hwang WL, Niemierko A, DuBois SG, Haas-Kogan DA.

Cancer. 2019 Apr 15;125(8):1357-1364. doi: 10.1002/cncr.31919. Epub 2019 Jan 2.

PMID:
30602061
10.

Long-term impact of a faculty mentoring program in academic medicine.

Efstathiou JA, Drumm MR, Paly JP, Lawton DM, O'Neill RM, Niemierko A, Leffert LR, Loeffler JS, Shih HA.

PLoS One. 2018 Nov 29;13(11):e0207634. doi: 10.1371/journal.pone.0207634. eCollection 2018.

11.

Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide.

Dworkin M, Mehan W, Niemierko A, Kamran SC, Lamba N, Dietrich J, Martinez-Lage M, Oh KS, Batchelor TT, Wen PY, Loeffler JS, Shih HA.

J Neurooncol. 2019 Mar;142(1):69-77. doi: 10.1007/s11060-018-03063-1. Epub 2018 Nov 28.

PMID:
30488294
12.

Evaluation of radiation-induced cardiac toxicity in breast cancer patients treated with Trastuzumab-based chemotherapy.

Abouegylah M, Braunstein LZ, Alm El-Din MA, Niemierko A, Salama L, Elebrashi M, Edgington SK, Remillard K, Napolitano B, Naoum GE, Sayegh HE, Gillespie T, Farouk M, Ismail AA, Taghian AG.

Breast Cancer Res Treat. 2019 Feb;174(1):179-185. doi: 10.1007/s10549-018-5053-y. Epub 2018 Nov 26.

PMID:
30478787
13.

Comparing Adjuvant vs Early-Salvage Radiotherapy After Radical Prostatectomy-Reply.

Hwang WL, Niemierko A, Efstathiou JA.

JAMA Oncol. 2018 Nov 1;4(11):1620-1621. doi: 10.1001/jamaoncol.2018.3552. No abstract available.

PMID:
30422248
14.

Radiation Therapy Outcomes Models in the Era of Radiomics and Radiogenomics: Uncertainties and Validation.

El Naqa I, Pandey G, Aerts H, Chien JT, Andreassen CN, Niemierko A, Ten Haken RK.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1070-1073. doi: 10.1016/j.ijrobp.2018.08.022. Epub 2018 Oct 18. No abstract available.

PMID:
30353869
15.

Clinical Impact of Tumor Mutational Burden in Neuroblastoma.

Hwang WL, Wolfson RL, Niemierko A, Marcus KJ, DuBois SG, Haas-Kogan D.

J Natl Cancer Inst. 2018 Oct 10. doi: 10.1093/jnci/djy157. [Epub ahead of print]

PMID:
30307503
16.

Effectiveness and tolerability of neoadjuvant pertuzumab-containing regimens for HER2-positive localized breast cancer.

Spring L, Niemierko A, Haddad S, Yuen M, Comander A, Reynolds K, Shin J, Bahn A, Brachtel E, Specht M, Smith BL, Taghian A, Jimenez R, Peppercorn J, Isakoff SJ, Moy B, Bardia A.

Breast Cancer Res Treat. 2018 Dec;172(3):733-740. doi: 10.1007/s10549-018-4959-8. Epub 2018 Sep 15.

PMID:
30220055
17.

Endocrine Deficiency As a Function of Radiation Dose to the Hypothalamus and Pituitary in Pediatric and Young Adult Patients With Brain Tumors.

Vatner RE, Niemierko A, Misra M, Weyman EA, Goebel CP, Ebb DH, Jones RM, Huang MS, Mahajan A, Grosshans DR, Paulino AC, Stanley T, MacDonald SM, Tarbell NJ, Yock TI.

J Clin Oncol. 2018 Oct 1;36(28):2854-2862. doi: 10.1200/JCO.2018.78.1492. Epub 2018 Aug 17.

18.

Proton Stereotactic Radiosurgery for Brain Metastases: A Single-Institution Analysis of 370 Patients.

Atkins KM, Pashtan IM, Bussière MR, Kang KH, Niemierko A, Daly JE, Botticello TM, Hurd MC, Chapman PH, Oh K, Loeffler JS, Shih HA.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):820-829. doi: 10.1016/j.ijrobp.2018.03.056. Epub 2018 Apr 4.

PMID:
29976494
19.

The role of proton beam therapy in central neurocytoma: A single-institution experience.

Kang KH, Schapira E, Niemierko A, Martinez-Lage M, Bussière MR, Yock TI, Loeffler JS, Butler WE, Carter BS, Shih HA.

Pract Radiat Oncol. 2018 Sep - Oct;8(5):e305-e311. doi: 10.1016/j.prro.2018.02.005. Epub 2018 Feb 16.

PMID:
29706302
20.

Left hippocampal dosimetry correlates with visual and verbal memory outcomes in survivors of pediatric brain tumors.

Zureick AH, Evans CL, Niemierko A, Grieco JA, Nichols AJ, Fullerton BC, Hess CB, Goebel CP, Gallotto SL, Weyman EA, Gaudet DE, Nartowicz JA, Ebb DH, Jones RM, MacDonald SM, Tarbell NJ, Yock TI, Pulsifer MB.

Cancer. 2018 May 15;124(10):2238-2245. doi: 10.1002/cncr.31143. Epub 2018 Mar 2.

21.

The impact of timing of immunotherapy with cranial irradiation in melanoma patients with brain metastases: intracranial progression, survival and toxicity.

Rahman R, Cortes A, Niemierko A, Oh KS, Flaherty KT, Lawrence DP, Sullivan RJ, Shih HA.

J Neurooncol. 2018 Jun;138(2):299-306. doi: 10.1007/s11060-018-2795-7. Epub 2018 Feb 16.

PMID:
29453679
22.

Clinical needs assessment for sexual health among cancer patients receiving pelvic radiation: Implications for development of a radiation oncology sexual health clinic.

Wo JY, Drapek LC, Niemierko A, Silvia B, Noé BN, Russo AL, Miyamoto DT, Hong TS, Efstathiou JA, Zietman AL, Dizon DS.

Pract Radiat Oncol. 2018 May - Jun;8(3):206-212. doi: 10.1016/j.prro.2017.11.004. Epub 2017 Nov 21.

PMID:
29426693
23.

Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features.

Hwang WL, Tendulkar RD, Niemierko A, Agrawal S, Stephans KL, Spratt DE, Hearn JW, Koontz BF, Lee WR, Michalski JM, Pisansky TM, Liauw SL, Abramowitz MC, Pollack A, Moghanaki D, Anscher MS, Den RB, Zietman AL, Stephenson AJ, Efstathiou JA.

JAMA Oncol. 2018 May 10;4(5):e175230. doi: 10.1001/jamaoncol.2017.5230. Epub 2018 May 10. Erratum in: JAMA Oncol. 2018 May 1;4(5):751.

24.

Differences in lung injury after IMRT or proton therapy assessed by 18FDG PET imaging.

Shusharina N, Liao Z, Mohan R, Liu A, Niemierko A, Choi N, Bortfeld T.

Radiother Oncol. 2018 Jul;128(1):147-153. doi: 10.1016/j.radonc.2017.12.027. Epub 2018 Jan 16.

PMID:
29352608
25.

Radiation Safety for Pregnant Workers at a Proton Facility.

Maquilan G, Bussière MR, McCormack J, Medich T, Niemierko A, Shih HA.

Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):560-564. doi: 10.1016/j.ijrobp.2017.11.016. Epub 2017 Nov 16.

PMID:
29306585
26.

The impact of different stereotactic radiation therapy regimens for brain metastases on local control and toxicity.

Jimenez RB, Alexander BM, Mahadevan A, Niemierko A, Rajakesari S, Arvold ND, Floyd SR, Oh KS, Loeffler JS, Shih HA.

Adv Radiat Oncol. 2017 Jun 6;2(3):391-397. doi: 10.1016/j.adro.2017.05.008. eCollection 2017 Jul-Sep.

27.

Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer.

Spring L, Greenup R, Niemierko A, Schapira L, Haddad S, Jimenez R, Coopey S, Taghian A, Hughes KS, Isakoff SJ, Ellisen LW, Smith BL, Specht M, Moy B, Bardia A.

J Natl Compr Canc Netw. 2017 Oct;15(10):1216-1223. doi: 10.6004/jnccn.2017.0158.

PMID:
28982747
28.

Clinical Outcomes in Patients With Metastatic Lung Cancer Treated With PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy.

Hwang WL, Niemierko A, Hwang KL, Hubbeling H, Schapira E, Gainor JF, Keane FK.

JAMA Oncol. 2018 Feb 1;4(2):253-255. doi: 10.1001/jamaoncol.2017.3808. No abstract available.

29.

Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasive Bladder Cancer.

Sanchez A, Wszolek MF, Niemierko A, Clayman RH, Drumm M, Rodríguez D, Feldman AS, Dahl DM, Heney NM, Shipley WU, Zietman AL, Efstathiou JA.

J Urol. 2018 Feb;199(2):407-415. doi: 10.1016/j.juro.2017.08.106. Epub 2017 Sep 1.

PMID:
28870862
30.

Risk Factors for Disease Progression After Postprostatectomy Salvage Radiation: Long-term Results of a Single-institution Experience.

Rodin D, Drumm M, Clayman R, Buscariollo DL, Galland-Girodet S, Eidelman A, Feldman AS, Dahl DM, McGovern FJ, Olumi AF, Niemierko A, Shipley WU, Zietman AL, Efstathiou JA.

Clin Genitourin Cancer. 2017 Aug 3. pii: S1558-7673(17)30236-7. doi: 10.1016/j.clgc.2017.07.026. [Epub ahead of print]

PMID:
28864223
31.

Assessment of the Utility of Laparoscopy and Peritoneal Cytology in the Staging of Pancreatic Cancer.

Mihalcik SA, Virani S, Hong TS, Niemierko A, Mino-Kenudson M, Kobayashi WK, Fernández-Del Castillo C, Mamon HJ.

Pancreas. 2017 Aug;46(7):e60-e62. doi: 10.1097/MPA.0000000000000866. No abstract available.

PMID:
28697144
33.

Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas.

Kim D, Niemierko A, Hwang WL, Stemmer-Rachamimov AO, Curry WT, Barker FG, Martuza RL, Oh KS, Loeffler JS, Shih HA.

J Neurosurg. 2018 Apr;128(4):1123-1132. doi: 10.3171/2016.11.JNS16913. Epub 2017 Jun 16.

PMID:
28621619
34.

Long-term quality of life after definitive treatment for prostate cancer: patient-reported outcomes in the second posttreatment decade.

Jang JW, Drumm MR, Efstathiou JA, Paly JJ, Niemierko A, Ancukiewicz M, Talcott JA, Clark JA, Zietman AL.

Cancer Med. 2017 Jul;6(7):1827-1836. doi: 10.1002/cam4.1103. Epub 2017 May 31.

35.

Irradiation of anatomically defined pelvic subsites and acute hematologic toxicity in anal cancer patients undergoing chemoradiation.

Rose B, Mitra D, Hong TS, Jee KW, Niemierko A, Drapek LN, Blaszkowsky LS, Allen JN, Murphy JE, Clark JW, Ryan DP, Wo JY.

Pract Radiat Oncol. 2017 Sep - Oct;7(5):e291-e297. doi: 10.1016/j.prro.2017.03.008. Epub 2017 Mar 23.

PMID:
28462895
36.

Gallbladder toxicity and high-dose ablative-intent radiation for liver tumors: Should we constrain the dose?

Tanguturi SK, Niemierko A, Wo JY, Nguyen KN, Prichard H, Zhu AX, Wolfgang JA, Hong TS.

Pract Radiat Oncol. 2017 Sep - Oct;7(5):e323-e329. doi: 10.1016/j.prro.2017.02.001. Epub 2017 Feb 9.

PMID:
28341320
37.

Long-term results of adjuvant versus early salvage postprostatectomy radiation: A large single-institutional experience.

Buscariollo DL, Drumm M, Niemierko A, Clayman RH, Galland-Girodet S, Rodin D, Feldman AS, M Dahl D, McGovern FJ, F Olumi A, Eidelman A, Shipley WU, Zietman AL, Efstathiou JA.

Pract Radiat Oncol. 2017 Mar - Apr;7(2):e125-e133. doi: 10.1016/j.prro.2016.10.010. Epub 2016 Oct 19.

PMID:
28274403
38.

Michael Goitein, 1939-2016: A Giant of Modern Medical Physics.

Suit H, Chen G, Bortfeld T, Smith A, Loeffler J, Epp E, Niemierko A, Goitein G.

Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):654-658. doi: 10.1016/j.ijrobp.2016.12.032. Epub 2016 Dec 24. No abstract available.

PMID:
28244402
39.

Tolerability and Long-term Outcomes of Dose-Painted Neoadjuvant Chemoradiation to Regions of Vessel Involvement in Borderline or Locally Advanced Pancreatic Cancer.

Wo JY, Niemierko A, Ryan DP, Blaszkowsky LS, Clark JW, Kwak EL, Lillemoe KD, Drapek LN, Zhu AX, Allen JN, Faris JE, Murphy JE, Nipp R, Fernandez-Del Castillo C, Ferrone CR, Hong TS.

Am J Clin Oncol. 2018 Jul;41(7):656-661. doi: 10.1097/COC.0000000000000349.

PMID:
28134673
40.

Improved local control with an aggressive strategy of preoperative (with or without intraoperative) radiation therapy combined with radical surgical resection for retroperitoneal sarcoma.

Hull MA, Molina G, Niemierko A, Haynes AB, Jacobson A, Bernstein KA, Chen YL, DeLaney TF, Mullen JT.

J Surg Oncol. 2017 May;115(6):746-751. doi: 10.1002/jso.24557. Epub 2017 Jan 27.

PMID:
28127762
41.

Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.

Giacalone NJ, Shipley WU, Clayman RH, Niemierko A, Drumm M, Heney NM, Michaelson MD, Lee RJ, Saylor PJ, Wszolek MF, Feldman AS, Dahl DM, Zietman AL, Efstathiou JA.

Eur Urol. 2017 Jun;71(6):952-960. doi: 10.1016/j.eururo.2016.12.020. Epub 2017 Jan 9.

PMID:
28081860
42.

Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy.

Krasnow RE, Drumm M, Roberts HJ, Niemierko A, Wu CL, Wu S, Zhang J, Heney NM, Wszolek MF, Blute ML, Feldman AS, Lee RJ, Zietman AL, Shipley WU, Efstathiou JA.

Eur Urol. 2017 Jul;72(1):54-60. doi: 10.1016/j.eururo.2016.12.002. Epub 2016 Dec 28.

PMID:
28040351
43.

Updated Outcome and Analysis of Tumor Response in Mobile Spine and Sacral Chordoma Treated With Definitive High-Dose Photon/Proton Radiation Therapy.

Kabolizadeh P, Chen YL, Liebsch N, Hornicek FJ, Schwab JH, Choy E, Rosenthal DI, Niemierko A, DeLaney TF.

Int J Radiat Oncol Biol Phys. 2017 Feb 1;97(2):254-262. doi: 10.1016/j.ijrobp.2016.10.006. Epub 2016 Oct 13.

PMID:
27986348
44.

Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy.

Braunstein LZ, Taghian AG, Niemierko A, Salama L, Capuco A, Bellon JR, Wong JS, Punglia RS, MacDonald SM, Harris JR.

Breast Cancer Res Treat. 2017 Jan;161(1):173-179. doi: 10.1007/s10549-016-4031-5. Epub 2016 Nov 3.

PMID:
27807809
45.

Clinical outcomes for patients after surgery and radiation therapy for mesenchymal chondrosarcomas.

De Amorim Bernstein K, Liebsch N, Chen YL, Niemierko A, Schwab JH, Raskin K, Lozano-Calderon SA, Cote G, Harmon DC, Choy E, Haynes A, Mullen J, Hornicek FJ, DeLaney TF.

J Surg Oncol. 2016 Dec;114(8):982-986. doi: 10.1002/jso.24435. Epub 2016 Oct 28.

PMID:
27790706
46.

Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer.

Mak KS, Smith AB, Eidelman A, Clayman R, Niemierko A, Cheng JS, Matthews J, Drumm MR, Nielsen ME, Feldman AS, Lee RJ, Zietman AL, Chen RC, Shipley WU, Milowsky MI, Efstathiou JA.

Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):1028-1036. doi: 10.1016/j.ijrobp.2016.08.023. Epub 2016 Aug 24.

PMID:
27727064
47.

Irradiation of FDG-PET-Defined Active Bone Marrow Subregions and Acute Hematologic Toxicity in Anal Cancer Patients Undergoing Chemoradiation.

Rose BS, Jee KW, Niemierko A, Murphy JE, Blaszkowsky LS, Allen JN, Lee LK, Wang Y, Drapek LC, Hong TS, Wo JY.

Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):747-54. doi: 10.1016/j.ijrobp.2015.12.006. Epub 2015 Dec 17.

PMID:
26972647
48.

Multi-criteria optimization achieves superior normal tissue sparing in a planning study of intensity-modulated radiation therapy for RTOG 1308-eligible non-small cell lung cancer patients.

Kamran SC, Mueller BS, Paetzold P, Dunlap J, Niemierko A, Bortfeld T, Willers H, Craft D.

Radiother Oncol. 2016 Mar;118(3):515-20. doi: 10.1016/j.radonc.2015.12.028. Epub 2016 Jan 28.

PMID:
26830694
49.

Thoracolumbar spinal cord tolerance to high dose conformal proton-photon radiation therapy.

Chowdhry VK, Liu L, Goldberg S, Adams JA, De Amorim Bernstein K, Liebsch NJ, Niemierko A, Chen YL, DeLaney TF.

Radiother Oncol. 2016 Apr;119(1):35-9. doi: 10.1016/j.radonc.2016.01.002. Epub 2016 Jan 11.

PMID:
26791929
50.

Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade.

Hwang WL, Marciscano AE, Niemierko A, Kim DW, Stemmer-Rachamimov AO, Curry WT, Barker FG 2nd, Martuza RL, Loeffler JS, Oh KS, Shih HA, Larvie M.

Neuro Oncol. 2016 Jun;18(6):863-72. doi: 10.1093/neuonc/nov285. Epub 2015 Nov 22.

Supplemental Content

Loading ...
Support Center